TransMedics Group's market cap is currently $2.52B. The company's EPS TTM is $0.933; its P/E ratio is 85.09; TransMedics Group is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 241.62M	$ 93.46M	$ 30.26M	$ 25.64M	$ 23.60M
Gross Profit	$ 154.09M	$ 65.27M	$ 21.16M	$ 16.64M	$ 13.86M
Operating Income	$ -28.73M	$ -31.44M	$ -39.43M	$ -26.38M	$ -29.60M
EBITDA	$ -7.60M	$ -28.96M	$ -38.49M	$ -23.15M	$ -27.93M
Net Income	$ -25.03M	$ -36.23M	$ -44.22M	$ -28.75M	$ -33.55M
Balance Sheet
Cash & Short-Term Investments	$ 394.81M	$ 201.18M	$ 92.45M	$ 125.64M	$ 80.69M
Total Assets	$ 706.05M	$ 277.15M	$ 134.89M	$ 152.03M	$ 105.30M
Total Debt	$ 515.95M	$ 67.56M	$ 8.60M	$ 34.66M	$ 34.15M
Net Debt	$ 121.13M	$ -133.63M	$ -16.98M	$ 10.08M	$ 14.05M
Total Liabilities	$ 568.85M	$ 89.77M	$ 67.04M	$ 48.13M	$ 50.65M
Stockholders' Equity	$ 137.20M	$ 187.38M	$ 67.85M	$ 103.89M	$ 54.65M
Cash Flow
Free Cash Flow	$ -192.09M	$ -57.72M	$ -32.38M	$ -30.72M	$ -32.45M
Operating Cash Flow	$ -13.03M	$ -45.82M	$ -28.86M	$ -30.27M	$ -32.29M
Investing Cash Flow	$ -193.95M	$ 54.51M	$ 29.27M	$ -41.60M	$ -60.50M
Financing Cash Flow	$ 400.42M	$ 167.93M	$ 1.39M	$ 75.55M	$ 92.72M

Currency in USD

TransMedics Group Earnings and Revenue History

Income Statement >

TransMedics Group Debt to Assets

Balance Sheet >

TransMedics Group Cash Flow

Cash Flow >

TransMedics Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing